Covista (CVSA) shares reacted to a strong Q1 2026 earnings report, with revenue and adjusted EPS ahead of market expectations and full year guidance raised. This put the education provider’s recent execution in sharper focus for investors.

The latest Q1 beat and guidance lift come after a steady build in momentum, with an 11.98% 90 day share price return and a 3 year total shareholder return of 183.77%, while the 1 year total shareholder return of 0.97% has been relatively flat.

If strong execution at Covista has you thinking about where else growth stories might emerge, it could be worth scanning 19 top founder-led companies

With the stock up strongly over 90 days and analysts’ average price target sitting above the current US$117 share price, you have to ask: is Covista still undervalued, or is the market already pricing in future growth?

Most Popular Narrative: 23.7% Undervalued

Covista's most followed valuation story anchors on a fair value of $153.25, which sits well above the last close of $117, and it leans heavily on long term education demand and cash generation assumptions.

Persistent health care workforce shortages in nursing, medicine and behavioral health create a structural need for large scale training capacity, which can support sustained demand for Covista's programs and underpin revenue growth.

Analysts behind this narrative are assuming steady expansion in both revenue and profit margins, along with a future earnings multiple that reflects investors remaining comfortable paying a premium for that potential growth runway.

Result: Fair Value of $153.25 (UNDERVALUED)

However, this depends on health care shortages and digital learning trends. Any easing of staffing gaps or a shift back to in person study could quickly weaken the thesis.

Next Steps

Feeling encouraged by how this story is shaping up, or still on the fence? Look over the details yourself and weigh the potential upside in context by checking the 5 key rewards.

Looking for more investment ideas?

If Covista is on your radar, do not stop there. Broaden your watchlist now so you are not late to the next opportunity.

• Spot potential value candidates early by scanning 51 high quality undervalued stocks, which highlights companies that pair quality with pricing that may not fully reflect their fundamentals.
• Strengthen the defensive side of your portfolio by reviewing the solid balance sheet and fundamentals stocks screener (44 results) to see which stocks combine financial resilience with underlying business quality.
• Explore underfollowed opportunities by using the screener containing 23 high quality undiscovered gems, where companies with strong fundamentals are not yet widely followed.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.